1,3-diaclyated,26,27-alkyl/haloalkyl vitamin D3 compounds and methods of use thereof

Details for Australian Patent Application No. 2004275815 (hide)

Owner BioXell S.p.A.

Inventors Colli, Enrico; Maeehr, Hubert; Adorini, Luciano; Uskokovic, Milan R.; Penna, Giuseppe

Agent Shelston IP

Pub. Number AU-A-2004275815

PCT Pub. Number WO2005/030222

Priority 0322395.5 24.09.03 GB; 60/505,735 24.09.03 US; 0404567.0 01.03.04 GB

Filing date 24 September 2004

Wipo publication date 7 April 2005

International Classifications

A61K 31/59 (2006.01) - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems

C07C 401/00 (2006.01) Irradiation products of cholesterol or its derivatives

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/030222 Priority application(s): WO2005/030222

22 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004275816-Controlled release formulations of opioid and nonopioid analgesics

2004275814-Tumor vaccine